← Eichor
Condition: Recurrent Colorectal Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Colorectal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patie
NA · 2 location(s) · Hospital St. Joseph, Marseille, France · NCT04938986Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
Phase 2 · 41 location(s) · UNICANCER · NCT06475352Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metas
Phase 1/Phase 2 · 1 location(s) · University of Chicago · NCT06349590Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cance
NA · 13 location(s) · City of Hope Medical Center · NCT07125729Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer
Phase 1/Phase 2 · 5 location(s) · STCube, Inc. · NCT06873763A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence
Phase N/A · 1 location(s) · Fudan University · NCT06903325A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumor
Phase 1/Phase 2 · 10 location(s) · A2 Biotherapeutics Inc. · NCT06682793Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable
NA · 1 location(s) · University Hospital, Ghent · NCT06193356KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Phase 1/Phase 2 · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07353645Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
Phase 2 · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT06229340Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer A
Phase 2 · 1 location(s) · Fudan University · NCT07604909A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
Phase N/A · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07469709Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
Phase 2 · 2 location(s) · Shanghai EpimAb Biotherapeutics Co., Ltd. · NCT07314294Recurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum:
NA · 5 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT06815406Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Phase 4 · 9 location(s) · Fudan University · NCT06090994Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
Phase N/A · 22 location(s) · Xi Shan Wang · NCT03349762Ga-68-FAPI-46 PET for CRC Recurrence Detection in Elevated CEA
NA · 1 location(s) · Koo Foundation Sun Yat-Sen Cancer Center · NCT06769828A Predictive Model for Recurrence of Colorectal Cancer Based on Multi-omics of Portal Vein Blood
Phase N/A · 1 location(s) · Peking University Shougang Hospital · NCT06524245Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer
NA · 1 location(s) · Fudan University · NCT06934018CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or
Phase 2 · 5 location(s) · Emory University · NCT07140679Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT06271941A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene M
NA · 2 location(s) · Chinese University of Hong Kong · NCT05592886MIMICC Study in Patients With Colorectal Cancer
NA · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07494201Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07226115Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in P
Phase 1/Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06307548Beyond TME Origins
NA · 4 location(s) · Imperial College London · NCT02292641Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery
Phase 3 · 11 location(s) · Surgimab · NCT03659448
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.